Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism

Detalles Bibliográficos
Autores principales: Haider, Zahra, Rajalingam, Kanendran, Khalid, Tanveer, Oswal, Dilip, Dwarakanath, Akshay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997697/
https://www.ncbi.nlm.nih.gov/pubmed/33820684
http://dx.doi.org/10.1016/j.ejim.2021.03.025
_version_ 1783670386907414528
author Haider, Zahra
Rajalingam, Kanendran
Khalid, Tanveer
Oswal, Dilip
Dwarakanath, Akshay
author_facet Haider, Zahra
Rajalingam, Kanendran
Khalid, Tanveer
Oswal, Dilip
Dwarakanath, Akshay
author_sort Haider, Zahra
collection PubMed
description
format Online
Article
Text
id pubmed-7997697
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.
record_format MEDLINE/PubMed
spelling pubmed-79976972021-03-29 Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism Haider, Zahra Rajalingam, Kanendran Khalid, Tanveer Oswal, Dilip Dwarakanath, Akshay Eur J Intern Med Letter to the Editor Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. 2021-06 2021-03-26 /pmc/articles/PMC7997697/ /pubmed/33820684 http://dx.doi.org/10.1016/j.ejim.2021.03.025 Text en Crown Copyright © 2021 Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Haider, Zahra
Rajalingam, Kanendran
Khalid, Tanveer
Oswal, Dilip
Dwarakanath, Akshay
Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism
title Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism
title_full Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism
title_fullStr Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism
title_full_unstemmed Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism
title_short Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism
title_sort intermediate dose thromboprophylaxis in sars-cov-2 related venous thrombo embolism
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997697/
https://www.ncbi.nlm.nih.gov/pubmed/33820684
http://dx.doi.org/10.1016/j.ejim.2021.03.025
work_keys_str_mv AT haiderzahra intermediatedosethromboprophylaxisinsarscov2relatedvenousthromboembolism
AT rajalingamkanendran intermediatedosethromboprophylaxisinsarscov2relatedvenousthromboembolism
AT khalidtanveer intermediatedosethromboprophylaxisinsarscov2relatedvenousthromboembolism
AT oswaldilip intermediatedosethromboprophylaxisinsarscov2relatedvenousthromboembolism
AT dwarakanathakshay intermediatedosethromboprophylaxisinsarscov2relatedvenousthromboembolism

Ejemplares similares